BAM-15 vs Tirzepatide
Moderate Research vs FDA Approved
synergistic Similar synergy expected as with semaglutide; helps overcome weight loss plateaus.
Molecular Data
BAM-15 Tirzepatide
Weight 326.28 Da 4,813.55 Da
Half-life ~1.7 hours ~5 days (120 hours)
Chain — 39 amino acids
Type Small molecule (not a peptide) Dual GLP-1/GIP agonist
Key Benefits
BAM-15
01 Increases fat oxidation without affecting food intake
02 Reduces body fat mass in research models
03 7-fold more potent than DNP with better safety
04 Does not cause dangerous hyperthermia
05 No effect on lean body mass
06 Improves insulin sensitivity
07 Orally bioavailable
08 Activates AMPK and PGC-1α pathways
09 Synergistic with GLP-1 agonists (semaglutide)
Tirzepatide
01 Dramatic weight loss (15-22% body weight)
02 Superior diabetes control
03 Reduced cardiovascular risk (26% reduction in MACE)
04 Improved insulin sensitivity
05 Appetite suppression
06 Preserved muscle mass with exercise
Dosing Protocols
BAM-15
25-50 mg oral / Once or twice daily with meals
Tirzepatide
2.5mg starting, titrate up to 5-15mg weekly / Once weekly (same day each week)
Weight loss initiation 2.5mg Once weekly x 4 weeks
Weight loss progression 5mg Once weekly
Weight loss optimization 7.5-10mg Once weekly
Maximum weight loss 12.5-15mg Once weekly
Diabetes management (mild) 5-7.5mg Once weekly
Diabetes management (severe) 10-15mg Once weekly
Side Effects
BAM-15
Generally well-tolerated in research
Possible mild increase in body temperature (less than DNP)
Tirzepatide
Nausea (mild to moderate, first 2-4 weeks)
Appetite reduction
Possible fatigue during adaptation
Diarrhea or constipation
Reduced food cravings
Contraindications
Hyperthyroidism or thyroid disorders
Heart conditions
Pregnancy or breastfeeding
Use of other mitochondrial uncouplers (DNP, FCCP)
Fever or active infection
Personal or family history of medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Pregnancy or breastfeeding
History of pancreatitis
Research Evidence
BAM-15 Tirzepatide
Status Moderate Research FDA Approved
References 4 studies 4 studies
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.